Published in Cancer Res on May 01, 2000
Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol (2004) 4.16
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell (2003) 3.68
Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood (2007) 2.83
Mammalian collagen IV. Microsc Res Tech (2008) 2.56
Three-dimensional context regulation of metastasis. Clin Exp Metastasis (2008) 2.49
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A (2003) 2.28
Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A (2001) 2.19
Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol (2001) 2.18
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer (2010) 2.13
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol (2008) 1.81
Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest (2005) 1.66
Ocular neovascularization. J Mol Med (Berl) (2013) 1.65
New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci (2002) 1.58
Type IV collagen-derived angiogenesis inhibitors. Microvasc Res (2007) 1.51
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev Cell (2009) 1.46
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr (2008) 1.32
COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet (2012) 1.26
Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng Part A (2011) 1.26
The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med (2007) 1.25
A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells. Proc Natl Acad Sci U S A (2008) 1.16
Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci (2010) 1.09
Extracellular matrix as an inductive scaffold for functional tissue reconstruction. Transl Res (2013) 1.09
Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. Am J Pathol (2005) 1.05
Antiangiogenic gene therapy of cancer: recent developments. J Transl Med (2004) 1.03
Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties. Biochem Biophys Res Commun (2007) 1.03
Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor. Exp Cell Res (2008) 1.02
Proteomic analysis of human aqueous humor using multidimensional protein identification technology. Mol Vis (2009) 1.01
Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta (2014) 0.99
Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice. J Cell Biochem (2009) 0.98
Molecular mediators of angiogenesis. J Burn Care Res (2010) 0.98
Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int J Biol Sci (2007) 0.98
Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen. Gene Regul Syst Bio (2007) 0.97
Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Blood (2007) 0.96
Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cells. Curr Eye Res (2010) 0.95
Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol (2009) 0.95
MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol (2013) 0.93
Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention. Circulation (2015) 0.93
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer (2009) 0.92
Molecular imaging of vessels in mouse models of disease. Eur J Radiol (2009) 0.92
Microvascular complications and diabetic retinopathy: recent advances and future implications. Future Med Chem (2013) 0.92
An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clin Exp Metastasis (2005) 0.91
FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1. Invest Ophthalmol Vis Sci (2009) 0.91
Tumor angiogenesis as a target for dietary cancer prevention. J Oncol (2011) 0.86
Integrated extracellular matrix signaling in mammary gland development and breast cancer progression. Histol Histopathol (2014) 0.86
Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine. PLoS One (2012) 0.85
MIG-17/ADAMTS controls cell migration by recruiting nidogen to the basement membrane in C. elegans. Proc Natl Acad Sci U S A (2008) 0.85
Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli. Clin Exp Med (2008) 0.84
Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin. Arterioscler Thromb Vasc Biol (2013) 0.84
Potential therapeutic implications of intracrine angiogenesis. Med Hypotheses (2007) 0.84
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. Biochim Biophys Acta (2015) 0.84
Alteration of angiogenic patterns on B16BL6 melanoma development promoted in Matrigel. Med Mol Morphol (2010) 0.84
Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix. Pharmaceuticals (Basel) (2011) 0.84
Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness. J Biol Chem (2012) 0.83
Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells. Cancer Cell Int (2007) 0.82
Why cellular stress suppresses adipogenesis in skeletal tissue, but is ineffective in adipose tissue: control of mesenchymal cell differentiation via integrin binding sites in extracellular matrices. Matrix Biol (2013) 0.82
Angiostatic activity of obtustatin as alpha1beta1 integrin inhibitor in experimental melanoma growth. Int J Cancer (2008) 0.82
Cellular actions and signaling by endostatin. Crit Rev Eukaryot Gene Expr (2002) 0.82
Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods. Metallomics (2012) 0.81
Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS One (2015) 0.80
L-arginine mediated renaturation enhances yield of human, α6 Type IV collagen non-collagenous domain from bacterial inclusion bodies. Protein Pept Lett (2012) 0.80
Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy. Arch Physiol Biochem (2008) 0.80
A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma. Am J Pathol (2001) 0.80
Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed Res Int (2014) 0.80
Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis. Mol Cell Proteomics (2011) 0.80
Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation. J Oncol (2011) 0.79
Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors. J Cancer Sci Ther (2013) 0.78
Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis. PLoS One (2013) 0.78
Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo. Sci Rep (2014) 0.78
Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma. PLoS One (2012) 0.78
Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions. Semin Cell Dev Biol (2009) 0.78
A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t. Graefes Arch Clin Exp Ophthalmol (2011) 0.78
Collagen type IV at the fetal-maternal interface. Placenta (2014) 0.77
Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation. Graefes Arch Clin Exp Ophthalmol (2006) 0.77
Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells. Clin Exp Nephrol (2005) 0.76
Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis. Mol Ther (2016) 0.76
In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma. Int J Clin Exp Pathol (2015) 0.75
Reconstruction is not renovation - the role of remodeling in asthma. J Asthma Allergy (2009) 0.75
Molecular underpinnings of corneal angiogenesis: advances over the past decade. Int J Ophthalmol (2016) 0.75
Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model. BMC Cancer (2017) 0.75
Effects of CASP5 gene overexpression on angiogenesis of HMEC-1 cells. Int J Clin Exp Pathol (2015) 0.75
Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts. Lab Invest (2015) 0.75
The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab (2017) 0.75
Preparation and partial characterization of monoclonal antibodies specific for the nascent non-triple helical form of the type IV collagen alpha 1 chain. Biochem Biophys Rep (2016) 0.75
Characterization of a non-fibrillar-related collagen in the mollusc Haliotis tuberculata and its biological activity on human dermal fibroblasts. Mar Biotechnol (NY) (2011) 0.75
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
The optimization principle in phylogenetic analysis tends to give incorrect topologies when the number of nucleotides or amino acids used is small. Proc Natl Acad Sci U S A (1998) 15.43
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Mosaic organization of DNA nucleotides. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1994) 10.43
Long-range correlations in nucleotide sequences. Nature (1992) 8.93
Surface density of calcium ions and calcium spikes in the barnacle muscle fiber membrane. J Gen Physiol (1967) 6.59
The anomalous rectification and cation selectivity of the membrane of a starfish egg cell. J Membr Biol (1974) 6.43
Head and neck cancer. N Engl J Med (1993) 6.33
E-CELL: software environment for whole-cell simulation. Bioinformatics (1999) 6.29
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (1997) 5.13
Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions. Science (1985) 5.00
Oligometastases. J Clin Oncol (1995) 4.95
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Requirement of stereospecific alignments for initiation from the simian virus 40 early promoter. Nature (1986) 4.77
Regulation of DNA-replication origins during cell-cycle progression. Nature (1998) 4.52
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
Effects of exercise training on older patients with major depression. Arch Intern Med (1999) 4.35
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature (2001) 4.28
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell (2001) 4.24
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17
Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol (1997) 3.67
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
Post-tetanic hyperpolarization and electrogenic Na pump in stretch receptor neurone of crayfish. J Physiol (1966) 3.42
Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol (1995) 3.35
Variant of penicillinase mediated by an R factor in Escherichia coli. J Bacteriol (1970) 3.33
Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis. J Bacteriol (1984) 3.27
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr (1989) 3.12
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A (1997) 3.06
Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science (1991) 3.06
Evolutionary motif and its biological and structural significance. J Mol Evol (1997) 3.03
Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1998) 2.94
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
Mis6, a fission yeast inner centromere protein, acts during G1/S and forms specialized chromatin required for equal segregation. Cell (1997) 2.88
Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet (1998) 2.87
Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med (2001) 2.87
cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol (2000) 2.83
Specific protein binding to the simian virus 40 enhancer in vitro. Mol Cell Biol (1986) 2.82
Bni1p and Bnr1p: downstream targets of the Rho family small G-proteins which interact with profilin and regulate actin cytoskeleton in Saccharomyces cerevisiae. EMBO J (1997) 2.80
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol (1997) 2.76
Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci U S A (1988) 2.73
Atomic Control of the SrTiO3 Crystal Surface. Science (1994) 2.72
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Isolation of Rickettsia tsutsugamushi antigenically different from Kato, Karp, and Gilliam strains from patients. Microbiol Immunol (1984) 2.70
The reaction of phenylglyoxal with arginine residues in proteins. J Biol Chem (1968) 2.67
The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer (2008) 2.67
Education is not enough: a systems failure in protecting battered women. Ann Emerg Med (1989) 2.66
A study of the workforce in emergency medicine. Ann Emerg Med (1998) 2.65
Calcium and potassium currents of the membrane of a barnacle muscle fibre in relation to the calcium spike. J Physiol (1969) 2.63
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int (2007) 2.61
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (1995) 2.61
A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol Cell Biol (1993) 2.61
Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol (1989) 2.58
Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) J Clin Invest (2000) 2.57
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (1995) 2.54
Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science (1992) 2.50
Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol (1996) 2.49
Endostatin induces endothelial cell apoptosis. J Biol Chem (1999) 2.49
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res (1983) 2.46
The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development (1999) 2.46
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 2.45
Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem (1998) 2.44
Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med (1994) 2.43
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol Cell Biol (1990) 2.41
In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies. Phys Med Biol (2001) 2.36
Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology (2000) 2.36
Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet (1990) 2.35
Membrane currents of the tunicate egg under the voltage-clamp condition. J Physiol (1976) 2.32
Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol (1999) 2.30
Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (1998) 2.29
Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med (1995) 2.29
Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature (2001) 2.28
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clin Cancer Res (2000) 2.28
Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene (2007) 2.27
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest (1996) 2.26
The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature (2001) 2.23
Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res (1995) 2.23
Two components of the calcium current in the egg cell membrane of the tunicate. J Physiol (1976) 2.22
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest (1988) 2.22
Analysis of polypeptide composition and antigenic components of Rickettsia tsutsugamushi by polyacrylamide gel electrophoresis and immunoblotting. Infect Immun (1985) 2.20
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem (2000) 2.19
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol (1992) 2.19
Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol (2001) 2.18